View Scopus Profile

Mark T Reding

Associate Professor, Medicine - Hematology, Oncology, Transplant

Research output per year

If you made any changes in Pure these will be visible here soon.

Projects

7 Active
29 Finished

7 results

Filter

Active

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels

BIOMARIN PHARMACEUTICAL, INC.

7/15/18 → 7/15/23

Project: Research project

Health Resources and Services Administration Grant

Fairview Health Services

6/1/18 → 5/31/20

Project: Research project

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels...

BIOMARIN PHARMACEUTICAL, INC.

5/1/18 → 7/15/23

Project: Research project

A Prospective Non-Interventional Study of Bleed

BIOMARIN PHARMACEUTICAL, INC.

2/15/18 → 12/31/23

Project: Research project

ECHO: Expanding Communications on Hemophilia-A Outcomes.

BAYER HEALTHCARE PHARMACEUTICALS

7/1/16 → 12/31/21

Project: Research project

Phase I/II/III Pharmacokinetic and Outcome Study of Insp

Inspiration Biopharmaceuticals, Inc.

5/14/10 → 12/31/20

Project: Research project

A multi-centre, randomised, double-blinded, controlled,

5/22/07 → 12/31/20

Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.